Merck & Co’s Carisma Therapeutics CARM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$577K Hold
1,473,240
0.27% 11
2025
Q1
$457K Hold
1,473,240
0.28% 11
2024
Q4
$617K Buy
+1,473,240
New +$617K 0.24% 11